Collagen Hair Strength Meta-analysis: What the Evidence Says
Collagen Hair Strength Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are sy
Quick Answer
Collagen Hair Strength Meta analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence aware guidance rather than medical advice.
Key Takeaways
- 01This page is generated only from sources stored in the Migaku evidence knowledge base.
- 02Current evidence mix: 2 systematic review.
- 03Claims should be interpreted with the source type, study design, population, and publication date in mind.
- 04This article is educational and does not replace care from a qualified clinician.
Collagen Hair Strength Meta-analysis: What the Evidence Says
Quick Answer
Collagen Hair Strength Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.
Key Takeaways
- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 2 systematic review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.
Evidence Map
| Source | Evidence type | Level | Date | Identifier |
|---|---|---|---|---|
| Evaluating the Effectiveness of Commercial Oral Supplements for Hair Growth: A Systematic Review and Meta‐Analysis | systematic review | 1 | 2026-04-09 | 10.1111/jocd.70817 |
| Risk factors for sacrococcygeal pilonidal sinus: a systematic review and meta-analysis supplemented by genetic causal assessment | systematic review | 1 | 2026-01-07 | 10.3389/fsurg.2025.1718589 |
What The Sources Report
- However, heightened public interest does not necessarily correlate with high-quality evidence supporting effectiveness. [Alanazi Razan (2026); evidence level 1]
- However, the overall quality of evidence reported in these studies is heterogeneous, with small sample sizes and inconsistent outcome measures. [Alanazi Razan (2026); evidence level 1]
- In Western countries, the incidence of PS is approximately 26 per 100,000 individuals, predominantly affecting young adults aged 15-30 years, with males exhibiting a fourfold higher risk than females. [Xu Xingli (2026); evidence level 1]
- Previous studies have associated PS with mechanical friction, local anatomical features, hair growth patterns, and inflammatory responses. [Xu Xingli (2026); evidence level 1]
How To Read This Evidence
Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.
Practical Interpretation
There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For collagen hair strength meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.
Limits Of This First Pass
This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.
References
- Alanazi Razan (2026). Evaluating the Effectiveness of Commercial Oral Supplements for Hair Growth: A Systematic Review and Meta‐Analysis. DOI: 10.1111/jocd.70817. PMCID: PMC13063204. PMID: 41954038. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13063204/
- Xu Xingli (2026). Risk factors for sacrococcygeal pilonidal sinus: a systematic review and meta-analysis supplemented by genetic causal assessment. DOI: 10.3389/fsurg.2025.1718589. PMCID: PMC12819706. PMID: 41573250. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12819706/
Safety Note
Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.
FAQ
Frequently Asked Questions
Medically reviewed
Last reviewed July 25, 2026 by Migaku Evidence Review
Related content
